Home › Funds › Marshall Wace › IRD
Marshall Wace position in IRD
OPUS GENETICS INC · Health Care
Latest position (Q2 2026)1.95M sh
Reported value held$8.00M
Portfolio Weight0.01%
First reportedQ4 2025
Last changeReduce
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 157.65K | $316.87K | New |
| Q1 2026 | 2.31M | $10.53M | Add |
| Q2 2026 | 1.95M | $8.00M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IRD
- BlackRock Inc 3.12M sh · $12.81M · Q2 2026
- Balyasny Asset Management 3.09M sh · $12.69M · Q2 2026
- Millennium Management 2.30M sh · $9.46M · Q2 2026
- Goldman Sachs Group 1.53M sh · $6.28M · Q2 2026
- Geode Capital Management 1.37M sh · $5.62M · Q2 2026
- Vanguard Group 2.32M sh · $4.67M · Q4 2025
- UBS Group AG 683.89K sh · $2.81M · Q2 2026
- Citadel Advisors 665.66K sh · $2.74M · Q2 2026
- Morgan Stanley 464.90K sh · $1.91M · Q2 2026
- Northern Trust Corp 442.15K sh · $1.82M · Q2 2026
- Two Sigma Investments 253.96K sh · $1.04M · Q2 2026